Biological Role of Uterine Glands in Pregnancy

子宫腺体在妊娠中的生物学作用

基本信息

  • 批准号:
    9977233
  • 负责人:
  • 金额:
    $ 32.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-15 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Infertility and pregnancy loss are common health disorders affecting women. Our long-term research goal is to define critical physiological and genetic pathways that regulate uterine development, function and regeneration in order to diagnose, treat, and prevent infertility and disease problems in women. This application is specifically focused on the glands of the endometrium that are characteristic features of all uteri and critical for pregnancy. Pregnancy loss is the most common complication of human gestation, and recurrent pregnancy loss and infertility are observed in uterine gland knockout animal models. The pioneer transcription factor forkhead box A2 (FOXA2) is expressed solely in the glands of the mouse and human uterus, a critical player in uterine development and function, and implicated in a variety of diseases (infertility, adenomyosis, endometriosis, adenocarcinoma). Recent evidence strongly supports the idea that uterine glands and, by inference, their products have biological roles in uterine receptivity, blastocyst/conceptus survival and implantation, and stromal cell decidualization, which are essential processes in pregnancy establishment. However, our understanding of uterine gland and FOXA2 biology is very incomplete, particular in humans. Guided by strong preliminary data, two specific aims are proposed: (1) FOXA2 regulation of uterine physiology; and (2) impact of uterine glands on stromal cell decidualization. An integrative systems biology approach employing a combination of innovative mouse models and human endometrium will be used to discover important conserved functions of uterine glands. The proposed aims are conceptually and technically innovative and together will have a broad impact on the field by filling a substantial gap in our fundamental knowledge of uterine biology and pregnancy loss. This application specifically targets NIH program announcement PA-16-160 entitled “NIH Research Project Grant (Parent R01)” and focuses on understanding early pregnancy loss and genetic basis of idiopathic female infertility, which is a major research priority of the Fertility and Infertility Branch of the NICHD. In the long term, an increased understanding of uterine gland biology is important for diagnosis, prevention, and treatment of fertility and pregnancy problems and also for regenerative medicine therapies aimed at organ replacement and stem cell therapies to treat infertility and disease in women.
不孕症和流产是影响妇女的常见健康疾病。我们的长期研究目标是 定义调节子宫发育、功能和再生的关键生理和遗传途径 以诊断、治疗和预防妇女的不孕症和疾病问题。该应用程序具体为 重点是子宫内膜的腺体,这是所有子宫的特征,对怀孕至关重要。 妊娠丢失是人类妊娠期最常见的并发症,反复妊娠丢失和不孕症 在子宫腺敲除动物模型中观察到。先锋转录因子叉头盒A2 FOXA 2仅在小鼠和人类子宫的腺体中表达,这是子宫发育的关键因素。 和功能,并涉及各种疾病(不孕症,子宫腺肌病,子宫内膜异位症,腺癌)。 最近的证据有力地支持了子宫腺及其产物具有生物学活性的观点。 在子宫容受性、胚泡/孕体存活和植入以及基质细胞蜕膜化中的作用, 这是怀孕的基本过程。然而,我们对子宫腺和 FOXA 2生物学非常不完整,特别是在人类中。在强有力的初步数据的指导下,两个具体目标 提出:(1)FOXA 2调节子宫生理;(2)子宫腺对基质细胞的影响 蜕膜化采用创新小鼠模型组合的综合系统生物学方法 和人子宫内膜将用于发现子宫腺的重要保守功能。拟议 目标在概念上和技术上都具有创新性,通过填补空白,将对该领域产生广泛影响 我们在子宫生物学和妊娠丢失的基础知识方面存在巨大差距。本申请具体 目标是NIH项目公告PA-16-160,标题为“NIH研究项目资助(父R 01)”,重点是 了解早期妊娠丢失和特发性女性不孕症的遗传基础,这是一个重大的研究 这是国家排雷中心生育和不育分支的优先事项。从长远来看, 子宫腺生物学对于诊断、预防和治疗生育和妊娠问题很重要 也用于旨在治疗不孕症的器官置换和干细胞疗法的再生医学疗法 和妇女的疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS E SPENCER其他文献

THOMAS E SPENCER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS E SPENCER', 18)}}的其他基金

Endometrial Basis for Infertility in Women with Recurrent Implantation Failure and Pregnancy Loss
反复着床失败和妊娠失败的女性不孕的子宫内膜基础
  • 批准号:
    10642892
  • 财政年份:
    2021
  • 资助金额:
    $ 32.16万
  • 项目类别:
Biological Role of Uterine Glands in Pregnancy
子宫腺体在妊娠中的生物学作用
  • 批准号:
    9761556
  • 财政年份:
    2018
  • 资助金额:
    $ 32.16万
  • 项目类别:
Biological Role of Uterine Glands in Pregnancy
子宫腺体在妊娠中的生物学作用
  • 批准号:
    10200105
  • 财政年份:
    2018
  • 资助金额:
    $ 32.16万
  • 项目类别:
Generation of a Model to Study Uterine Gland Function
研究子宫腺功能的模型的生成
  • 批准号:
    9360767
  • 财政年份:
    2016
  • 资助金额:
    $ 32.16万
  • 项目类别:
Biological Role of Endometrial Glands in Uterine Function
子宫内膜腺在子宫功能中的生物学作用
  • 批准号:
    9095068
  • 财政年份:
    2013
  • 资助金额:
    $ 32.16万
  • 项目类别:
System biology approach to understand endometrial receptivity & pregnancy loss
了解子宫内膜容受性的系统生物学方法
  • 批准号:
    8514668
  • 财政年份:
    2012
  • 资助金额:
    $ 32.16万
  • 项目类别:
System biology approach to understand endometrial receptivity & pregnancy loss
了解子宫内膜容受性的系统生物学方法
  • 批准号:
    9128673
  • 财政年份:
    2012
  • 资助金额:
    $ 32.16万
  • 项目类别:
Systems biology approach to understand endometrial receptivity & pregnancy loss
了解子宫内膜容受性的系统生物学方法
  • 批准号:
    8335206
  • 财政年份:
    2012
  • 资助金额:
    $ 32.16万
  • 项目类别:
Endogenous Retroviruses and Placental Morphogenesis
内源性逆转录病毒和胎盘形态发生
  • 批准号:
    8299715
  • 财政年份:
    2011
  • 资助金额:
    $ 32.16万
  • 项目类别:
Endogenous Retroviruses and Placental Morphogenesis
内源性逆转录病毒和胎盘形态发生
  • 批准号:
    7415164
  • 财政年份:
    2007
  • 资助金额:
    $ 32.16万
  • 项目类别:

相似国自然基金

大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
  • 批准号:
    30840003
  • 批准年份:
    2008
  • 资助金额:
    12.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
  • 批准号:
    478914
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
  • 批准号:
    23K14913
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
  • 批准号:
    23K15035
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
  • 批准号:
    10657069
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
  • 批准号:
    10442874
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
  • 批准号:
    23K08326
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
  • 批准号:
    23K14614
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
  • 批准号:
    23K15075
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
  • 批准号:
    23H02698
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
  • 批准号:
    10743611
  • 财政年份:
    2023
  • 资助金额:
    $ 32.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了